Sodium hydride → HCID 86618536, compound
Reaction equation
[Cl:1][C:2]1[CH:15]=[CH:14][C:5]([CH2:6][N:7]2[CH2:12][CH2:11][CH:10]([NH2:13])[CH2:9][CH2:8]2)=[CH:4][C:3]=1[O:16][CH2:17][CH3:18].[H-].[Na+].[Cl:21][C:22]1[N:27]=[C:26](Cl)[C:25]([CH3:29])=[CH:24][N:23]=1>CN(C=O)C>[Cl:1][C:2]1[CH:15]=[CH:14][C:5]([CH2:6][N:7]2[CH2:12][CH2:11][CH:10]([NH:13][C:24]3[C:25]([CH3:29])=[CH:26][N:27]=[C:22]([Cl:21])[N:23]=3)[CH2:9][CH2:8]2)=[CH:4][C:3]=1[O:16][CH2:17][CH3:18]Participants
5
Procedure
To a solution of 1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-ylamine (40.3 mg, 0.15 mmol, 1.2 equiv; intermediate A2) in dry DMF (1.5 mL) was added sodium hydride (6.6 mg, 0.15 mmol, 1.2 equiv; 55% free-flowing powder moistened with oil) and the reaction mixture stirred at rt under Ar. After 2 h, 2,4-dichloro-5-methyl-pyrimidine (20.4 mg, 0.125 mmol, 1.0 equiv; commercially available) was added and the mixture heated to 120° C. for 48 h. Removal of the solvent under reduced pressure and purification by preparative HPLC on reversed phase eluting with a gradient of acetonitrile/water provided 3.7 mg (8%) of the title compound. MS (ISP): 395.2 [M+H]+.
Workup
- additioncommercially available) was added
- temperaturethe mixture heated to 120° C. for 48 h
- customRemoval of the solvent
- customunder reduced pressure and purification by preparative HPLC on reversed phase
- washeluting with a gradient of acetonitrile/water
Sources & evidence
- ORD record
- ord-b643257195bc49f3a07461eeb2169a2a
- Source dataset
- uspto-grants-2011_06
- Patent number
- US07968568B2
Reaction notes
Loading…